Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Tumor
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Tumor

[0399-CSB-YP024077HU-100ug.] E. coli Rec. Human Cellular tumor antigen p53(TP53) 100ug.
E. coli Rec. Human Cellular tumor antigen p53(TP53) 100ug.
695.00 € 695.0 EUR
[0677-QY-E10880-96T] Rat Tumor necrosis factor α(TNF-α)ELISA Test - 96T
Rat Tumor necrosis factor α(TNF-α)ELISA Test - 96T
840.00 € 840.0 EUR
[0399-CSB-E06998Rb-96T] Rabbit Tumor necrosis factor α,TNFα ELISA Test - 96T
Rabbit Tumor necrosis factor α,TNFα ELISA Test - 96T
792.00 € 792.0 EUR
[0544-MBS2021700-96T] Rabbit Tumor Necrosis Factor Alpha (TNFa) ELISA Test - 96 wells plate
Rabbit Tumor Necrosis Factor Alpha (TNFa) ELISA Test - 96 wells plate
884.00 € 884.0 EUR
[0006-E07A0616-96] Porcine Tumor Necrosis Factor Alpha ELISA Test
Porcine Tumor Necrosis Factor Alpha ELISA Test
825.00 € 825.0 EUR
[0036-T2235152-9] Paraffin Tissue Block - Human Lung Tumor: Small Cell Carcinoma; 10 different donors
Paraffin Tissue Block - Human Lung Tumor: Small Cell Carcinoma; 10 different donors
2,290.00 € 2290.0 EUR
[0314-0710-0097] Oncology - Seraseq Tri-Level Tumor Mutation DNA
Oncology - Seraseq Tri-Level Tumor Mutation DNA
4,796.00 € 4796.0 EUR
[0314-0710-1310] Oncology - Seraseq FFPE Tumor Mutational Burden
Oncology - Seraseq FFPE Tumor Mutational Burden
1,926.00 € 1926.0 EUR
[0314-0710-1307] Oncology - Seraseq FFPE Tumor Mutational Burden
Oncology - Seraseq FFPE Tumor Mutational Burden
1,926.00 € 1926.0 EUR
[0131-BCN1021] Multiple tumor tissue array covers 53 types of benign, malignant,  regional lymph node and distant metastasis tumors with normal tissues as controls, including pathology grade, TNM/Stage(AJCC 8th edition), 102 cases/102 cores(core size 1.5mm)
Multiple tumor tissue array covers 53 types of benign, malignant, regional lymph node and distant metastasis tumors with normal tissues as controls, including pathology grade, TNM/Stage(AJCC 8th edition), 102 cases/102 cores(core size 1.5mm)
381.00 € 381.0 EUR
[0131-MNT241a] Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, including TNM, stage and pathology grade, 12 cases/ 24 cores, replacing MNT241,Unstained, fresh cut, unbaked
Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, including TNM, stage and pathology grade, 12 cases/ 24 cores, replacing MNT241,Unstained, fresh cut, unbaked
243.20 € 243.20000000000002 EUR
[0131-MNT241as] Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, including TNM, stage and pathology grade, 12 cases/ 24 cores, replacing MNT241,H&E, fresh cut, unbaked
Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, including TNM, stage and pathology grade, 12 cases/ 24 cores, replacing MNT241,H&E, fresh cut, unbaked
243.20 € 243.20000000000002 EUR
[0131-TE482A] Multiple testis tumor and testis tissue array, including TNM and clinical stage, 24 cases/48 cores, replacing TE482
Multiple testis tumor and testis tissue array, including TNM and clinical stage, 24 cases/48 cores, replacing TE482
279.00 € 279.0 EUR
[0131-HN721] Multiple sites of head and neck tumor ad normal tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores
Multiple sites of head and neck tumor ad normal tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores
422.00 € 422.0 EUR
[0131-BCN721b] Multiple organ tumor with adjacent normal tissue array, including pathology grade, TNM and clinical stage, replaing BCN721a, unstained
Multiple organ tumor with adjacent normal tissue array, including pathology grade, TNM and clinical stage, replaing BCN721a, unstained
379.00 € 379.0 EUR
[0131-BC001157a] Multiple organ tumor (17 kinds of organ, each organ has 1-2 pathological types with 9 normal tissue and 8 adjacent tissue as control) tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores (core size 1.5mm ), replacing BC001157, fresh cut, unbaked, unstained
Multiple organ tumor (17 kinds of organ, each organ has 1-2 pathological types with 9 normal tissue and 8 adjacent tissue as control) tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores (core size 1.5mm ), replacing BC001157, fresh cut, unbaked, unstained
383.50 € 383.5 EUR
[0131-BC001157as] Multiple organ tumor (17 kinds of organ, each organ has 1-2 pathological types with 9 normal tissue and 8 adjacent tissue as control) tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores (core size 1.5mm ), replacing BC001157, fresh cut, unbaked, H&E
Multiple organ tumor (17 kinds of organ, each organ has 1-2 pathological types with 9 normal tissue and 8 adjacent tissue as control) tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores (core size 1.5mm ), replacing BC001157, fresh cut, unbaked, H&E
383.50 € 383.5 EUR
[1028-XHN-802c] Multiple head and neck tumor with normal tissue array (2005 WHO classification), including pathology grade, TNM and clinical stage (AJCC 8th edition) - 80 cases/80 cores
Multiple head and neck tumor with normal tissue array (2005 WHO classification), including pathology grade, TNM and clinical stage (AJCC 8th edition) - 80 cases/80 cores
495.00 € 495.0 EUR
[0399- CSB-E04741m-96T] Mouse Tumor necrosis factor α,TNF-α ELISA Test - 96T
Mouse Tumor necrosis factor α,TNF-α ELISA Test - 96T
990.00 € 990.0 EUR
[0639‐abx511924] Mouse Tumor Necrosis Factor Alpha (TNFA) ELISA Test ‐ 96 tests
Mouse Tumor Necrosis Factor Alpha (TNFA) ELISA Test ‐ 96 tests
597.02 € 597.02 EUR
  • 1
  • 2
  • 3
  • 4

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)